Phase
Condition
Hair Loss
Alopecia
Treatment
Doxycyline
Triamcinolone Acetonide
Minoxidil
Clinical Study ID
Ages 18-60 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
African-American women, ages 18-60 years old
with a clinical diagnosis and biopsy-proven CCCA, with Central Scalp Alopecia Scaleseverity 1 through 4 will be included in this study
These subjects will be seen and treated in Wake Forest Baptist Health DermatologyOutpatient Clinic
Exclusion
Exclusion Criteria:
Patients with other forms of hair loss in addition to CCCA will be excluded
Other patients to be excluded are those with other forms of inflammatory scalpdisease (with the exception of mild seborrheic dermatitis)
patients who have had topical treatment for CCCA within the past 4 months (includingtopical steroids, topical minoxidil, or any other topical hair regrowth medication)
patients who have been on a long-term oral antibiotics for hair loss within the pastyear
patients who have undergone more than two rounds of intralesional steroid injectionsto the scalp in the past one year.
Study Design
Study Description
Connect with a study center
Wake Forest Baptist Health Department of Dermatology
Winston-Salem, North Carolina 27157
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.